deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT01897610

Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC

Randomized, Open-label and Multi-center Clinical Trial to Evaluate the Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced Hepatocellular Carcinoma

Sponsor: GC Cell Corporation

Conditions Advanced Hepatocellular Carcinoma
Interventions Immuncell-LC
Updated 9 times since 2017 Last updated: Jun 22, 2023 Started: Dec 31, 2013 Primary completion: Jul 31, 2017 Completion: Jul 4, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01897610, this PHASE2 trial focuses on Advanced Hepatocellular Carcinoma and remains completed. Sponsored by GC Cell Corporation, it has been updated 9 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshotActive Not Recruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshotCompleted~Jan 2022 – ~Jul 2023 · 18 months · monthly snapshotCompleted~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jul 2023 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jan 2022 — Jul 2023 [monthly]

    Completed PHASE2

▶ Show 4 earlier versions

  1. Jan 2021 — Jan 2022 [monthly]

    Completed PHASE2

  2. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  3. Oct 2017 — Jun 2018 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Jan 2017 — Oct 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GC Cell Corporation
Data source: GC Cell Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations